A unique product development partnership seeks to address the need for new therapeutics for Chagas disease by developing and testing vaccine candidate antigens that would eventually comprise a ...

As an alternative to chemotherapy, an injectable therapeutic Chagas disease vaccine is under development to prevent or delay Chagasic cardiomyopathy in patients with indeterminate or determinate ...

Chagas disease, caused by the Trypanosoma cruzi parasite and transmitted by insects in Latin America is among the most common tropical diseases, and so far without effective vaccine. A study ...

Mexican and American researchers are working on developing a vaccine to stop Chagas disease, which is expected to be available for the population within the next three years. Involved in the ...

which have been patented and are progressing toward the first-ever clinical trial of Chagas disease vaccine candidates. "Dr. Farani's more sensitive approach to DNA extraction represents a ...

Chagas disease is a tropical illness caused by the parasite Trypanosoma cruzi, which is most commonly spread by the fecal matter of triatomine bugs - also known as "kissing bugs" because they bite ...

Known as the kissing bug, this insect carries a parasite that can cause the potentially fatal Chagas disease. "Kissing bugs are not your typical insect. Feeding on blood—mostly at night—they ...

The advantages of a therapeutic Chagas disease vaccine compared with benznidazole alone (the current major competing product in clinical use) could include the following: Three recent ...

Chagas disease isn’t well-known in America ... They can cause serious side effects, especially in older people. There is no vaccine. The best way to prevent it is by avoiding triatomine bugs.